ueda2015 giudelines type 1 dr.hesham el-hefnawy
TRANSCRIPT
![Page 1: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/1.jpg)
Prof. Dr. Mohamed Hesham El-Hefnawy
| Confidential1
Preferred language: English
Who is Prof. El-Hefnawy?
-Dean of Egypt National Institute for Diabetes & Endocrinology-Certified Medical Diabetes Education Instructor (ADA, Verginia)
-Professor degree of Diabetes & Endocrinology in National Institute of Diabetes & Endocrinology (NIDE), Cairo, Egypt.
-Head of research unit in National Institute of diabetes & Endocrinology (NIDE).-Member of Research Ethics Committee of General Organization of Teaching
Hospitals & Institutes, (GOTHI).-Reviewer in the African Research Academy for evaluation of the researches to be
published in the International Journals of the Academy.-Member of ISPAD, (International Society of Pediatric & Adolescence Diabetes).-Sharing in writing a chapter of international Text-Book of Diabetes in Croatia in
2011.-International published researches in field of Diabetes management, epidemiology,
educational programs,….etc. -Contact details: [email protected]
![Page 2: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/2.jpg)
Type 1 Diabetes Guidelines ?
Prof. M. Hesham El HefnawyDean of National Institute of Diabetes & Endocrinology
E mail: [email protected]
![Page 3: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/3.jpg)
Is There Is Type 1 Guidelines ?
![Page 4: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/4.jpg)
![Page 5: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/5.jpg)
![Page 6: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/6.jpg)
![Page 7: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/7.jpg)
![Page 8: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/8.jpg)
![Page 9: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/9.jpg)
![Page 10: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/10.jpg)
![Page 11: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/11.jpg)
![Page 12: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/12.jpg)
![Page 13: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/13.jpg)
IndividualizedIndividualized
Individualized
Individualized
![Page 14: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/14.jpg)
![Page 15: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/15.jpg)
![Page 16: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/16.jpg)
![Page 17: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/17.jpg)
![Page 18: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/18.jpg)
![Page 19: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/19.jpg)
![Page 20: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/20.jpg)
![Page 21: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/21.jpg)
![Page 22: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/22.jpg)
![Page 23: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/23.jpg)
![Page 24: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/24.jpg)
INSULIN•* Insulin is essential for life in type 1 D.M.
•* We have to reach to a strict control of D.M.(Glycated HbA1c < 7%).
•* Strict control is not to give multiple injections, but it is better to achieve excellent control ,to avoid most of the diabetic complications, by the least number of injections to avoid the lipodystrophy and for psychological reasons also.
![Page 25: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/25.jpg)
Initial insulin dose:
• 0.4 - 0.8 U/kg/Day• Q: Why this wide range of the initial insulin
dose?– Family history of type 2 diabetes.– Lifestyle (sedentary vs. active). – Adiposity.– Gender (males usually require more than females). – Any remaining endogenous insulin secretion.– Concomitant illness.
•
![Page 26: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/26.jpg)
Q: How to classify the initial insulin dose?
Basal: 40-50% of total dose.
•Bolus: 50-60% of total dose
![Page 27: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/27.jpg)
Basal Insulin:
– NPH or Detimir twice daily.
– Galargin can be administered once or twice dailey. If it is decided to start with once daily basal insulin, it is usually administered at bedtime.
– Titration of basal insulin • By observing glucose trends during periods of fasting.
• The median glucose level before breakfast
• Any information on glucose levels during the night when glycemia is not contaminated by food or prandial insulin.
•
![Page 28: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/28.jpg)
Bolus (Prandial) Insulin
– Typical doses: 1 unit per 10 to 15 grams of carbohydrate.– But in obese patients: 1 unit per 5 grams of carbohydrate.– While thin patients: 1 unit per 20 grams of carbohydrate– Titration of bolus insulin dose
• Insulin Sensitivity Factor: The drop in blood glucose level (mg/dl), caused by each unit of insulin taken.
• For patients who use Regular (short-acting) insulin: Use 1500 rule.
Divide 1500 by the total daily dose of Regular insulin, in units. • For patients who use the Rapidly-acting Insulin Analogues: Use
1800 rule. Divide 1800 by the total daily dose of rapidly acting insulin analogues, in units.
![Page 29: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/29.jpg)
Q: When higher doses (basal and bolus) of insulin may be needed?
– If your patient have an infection.
– If your patient reduce his level of activity.
– If you are prescribed a medicine that changes insulin sensitivity (such as Prednisone).
– If your patient are under emotional stress.
– During adolescence.
– During pregnancy.
![Page 30: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/30.jpg)
Q: When lower doses (basal and bolus) of insulin may be needed?
– If your patient become more active.
– If your patient have problems with kidney function.
![Page 31: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/31.jpg)
Methods of insulin injection
• Insulin syringes; – Insulin syringes must have a measuring scale
consistent with the insulin concentration (e.g. U 100 syringes for insulin concentration 100 U/ml).
– Injections by syringe are usually given into the deep SC tissue through a two-finger pinch of skin at a 45angle. A 90 angle can be used if the SC fat is thick enough.
• Pen injector devices:– Requires careful wait of 15 seconds after pushing in
the plunger helps to ensure complete expulsion of insulin through the needle.
![Page 32: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/32.jpg)
Why These Slides are in White color??
![Page 33: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/33.jpg)
Because ..
![Page 34: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/34.jpg)
![Page 35: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/35.jpg)
![Page 36: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/36.jpg)
![Page 37: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/37.jpg)
![Page 38: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/38.jpg)
![Page 39: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/39.jpg)
![Page 40: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/40.jpg)
![Page 41: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/41.jpg)
![Page 42: Ueda2015 giudelines type 1 dr.hesham el-hefnawy](https://reader033.vdocuments.us/reader033/viewer/2022052215/55cb4808bb61eb8a5e8b4643/html5/thumbnails/42.jpg)
اللهم احفظ مصر دائما
Thank you